Literature DB >> 18407468

Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4.

Tamio Suzuki1, Yasushi Tomita.   

Abstract

Patients with OCA are characterized by reduced skin and hair pigmentation and consequent photosensitivity, actinic damage and risk of skin cancer, and by reduced visual acuity and nystagmus. Our survey of Japanese patients revealed that OCA1 was the most frequent type at 34%, while type 2 was present at less than 10%. OCA3 was absent. OCA4, which is a rare type worldwide, was the second most frequent type at 27%. Unexpectedly 10% of the patients turned out to be Hermansky-Pudlak syndrome type 1. Furthermore, the pathogenic p.A481T allele for OCA2, which has 70% melanogenesis activity, was found in approximately 12% of normally pigmented people, indicating that sub-clinical OCA2 might be more frequent in the Japanese than currently thought. And OCA4 is one of the most common types in Japanese patients, despite being rare worldwide.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407468     DOI: 10.1016/j.jdermsci.2007.12.008

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  23 in total

1.  Update on the regulation of mammalian melanocyte function and skin pigmentation.

Authors:  Taisuke Kondo; Vincent J Hearing
Journal:  Expert Rev Dermatol       Date:  2011-02-01

2.  Molecular analysis of Korean patients with oculocutaneous albinism.

Authors:  Shin Hae Park; Hyojin Chae; Yonggoo Kim; Myungshin Kim
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

3.  Unrevealing the role of P-protein on melanosome biology and structure, using siRNA-mediated down regulation of OCA2.

Authors:  Sangjoo Park; V K Morya; Dong Hoang Nguyen; Birendra K Singh; Hyang-Bok Lee; Eun-Ki Kim
Journal:  Mol Cell Biochem       Date:  2015-02-06       Impact factor: 3.396

4.  Functional interactions between OCA2 and the protein complexes BLOC-1, BLOC-2, and AP-3 inferred from epistatic analyses of mouse coat pigmentation.

Authors:  Diego J Hoyle; Imilce A Rodriguez-Fernandez; Esteban C Dell'angelica
Journal:  Pigment Cell Melanoma Res       Date:  2010-12-17       Impact factor: 4.693

5.  Two novel splicing mutations in the SLC45A2 gene cause Oculocutaneous Albinism Type IV by unmasking cryptic splice sites.

Authors:  Letizia Straniero; Valeria Rimoldi; Giulia Soldà; Lucia Mauri; Emanuela Manfredini; Elena Andreucci; Sara Bargiacchi; Silvana Penco; Giovanni P Gesu; Alessandra Del Longo; Elena Piozzi; Rosanna Asselta; Paola Primignani
Journal:  J Hum Genet       Date:  2015-05-28       Impact factor: 3.172

Review 6.  Pigmentation and vision: Is GPR143 in control?

Authors:  Brian S McKay
Journal:  J Neurosci Res       Date:  2018-05-14       Impact factor: 4.164

7.  Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.

Authors:  Jason E Hawkes; Pamela B Cassidy; Prashiela Manga; Raymond E Boissy; David Goldgar; Lisa Cannon-Albright; Scott R Florell; Sancy A Leachman
Journal:  J Dermatol Sci       Date:  2012-10-13       Impact factor: 4.563

8.  Identification of a Homozygous Missense Mutation in the TYR Gene in a Chinese Family with OCA1.

Authors:  Yan Wang; Yi-Fan Zhou; Na Shen; Yao-Wu Zhu; Kun Tan; Xiong Wang
Journal:  Curr Med Sci       Date:  2018-10-20

Review 9.  [Oculocutaneous and ocular albinism].

Authors:  A S Kubasch; M Meurer
Journal:  Hautarzt       Date:  2017-11       Impact factor: 0.751

10.  Evident hypopigmentation without other ocular deficits in Dutch patients with oculocutaneous albinism type 4.

Authors:  C C Kruijt; N E Schalij-Delfos; G C de Wit; R J Florijn; M M van Genderen
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.